Schedule 13G ownership disclosure

Cynapsus Therapeutics Inc.

Security class unavailable · CUSIP: 23257Y859

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950142-16-002989
Form type
SC 13G/A
Filer
AISLING CAPITAL III LP
CIK
CIK 1444717
Filed
Feb 05, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub